chr19-7641843-C-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_006949.4(STXBP2):​c.568C>T​(p.Arg190Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000529 in 1,554,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R190H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00054 ( 0 hom. )

Consequence

STXBP2
NM_006949.4 missense

Scores

6
10
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1O:1

Conservation

PhyloP100: 1.85

Publications

14 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23708275).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000407 (62/152306) while in subpopulation NFE AF = 0.000706 (48/68010). AF 95% confidence interval is 0.000547. There are 0 homozygotes in GnomAd4. There are 29 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.568C>T p.Arg190Cys missense_variant Exon 7 of 19 ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.568C>T p.Arg190Cys missense_variant Exon 7 of 19 1 NM_006949.4 ENSP00000221283.4 Q15833-1
ENSG00000268400ENST00000698368.1 linkn.*671C>T non_coding_transcript_exon_variant Exon 9 of 20 ENSP00000513686.1 A0A8V8TM65
ENSG00000268400ENST00000698368.1 linkn.*671C>T 3_prime_UTR_variant Exon 9 of 20 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.000407
AC:
62
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000706
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000483
AC:
76
AN:
157426
AF XY:
0.000415
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000795
Gnomad ASJ exome
AF:
0.00237
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000647
Gnomad NFE exome
AF:
0.000786
Gnomad OTH exome
AF:
0.000450
GnomAD4 exome
AF:
0.000542
AC:
760
AN:
1402616
Hom.:
0
Cov.:
32
AF XY:
0.000526
AC XY:
364
AN XY:
692330
show subpopulations
African (AFR)
AF:
0.0000316
AC:
1
AN:
31690
American (AMR)
AF:
0.0000828
AC:
3
AN:
36226
Ashkenazi Jewish (ASJ)
AF:
0.00250
AC:
63
AN:
25184
East Asian (EAS)
AF:
0.0000278
AC:
1
AN:
35934
South Asian (SAS)
AF:
0.0000376
AC:
3
AN:
79758
European-Finnish (FIN)
AF:
0.000163
AC:
8
AN:
49114
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4658
European-Non Finnish (NFE)
AF:
0.000595
AC:
644
AN:
1081964
Other (OTH)
AF:
0.000637
AC:
37
AN:
58088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000407
AC:
62
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.000389
AC XY:
29
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41570
American (AMR)
AF:
0.000196
AC:
3
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000706
AC:
48
AN:
68010
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000914
Hom.:
0
Bravo
AF:
0.000348
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000366
AC:
3
ExAC
AF:
0.000214
AC:
24

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial hemophagocytic lymphohistiocytosis 5 Uncertain:3Benign:1Other:1
Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STXBP2 NM_006949 exon 7 p.Arg190Cys (c.568C>T): This variant has been reported in the literature in 1 individual with hemophagocytic lymphohistiocytosis as a double heterozygote (Zhang 2014 PMID:24916509). This variant is present in 0.2% (21/8488) of Ashkenazi Jewish alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs370053399). This variant is present in ClinVar (Variation ID:404841). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

May 28, 2016
Division of Human Genetics, Children's Hospital of Philadelphia
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Dominant-negative variant assoc w/fHLH in 1 infant [Benavides et al 2020] -

May 26, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:2
Jun 11, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 19, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: STXBP2 c.568C>T (p.Arg190Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00048 in 157426 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in STXBP2 causing Familial Hemophagocytic Lymphohistiocytosis (0.00048 vs 0.0022), allowing no conclusion about variant significance. c.568C>T has been reported in the literature in heterozygous individuals affected with Familial Hemophagocytic Lymphohistiocytosis (e.g. Zhang_2014, Benavides_2020, Vinas-Gimenez_2021), and some were reported to also have variants in other genes. These reports do not provide unequivocal conclusions about association of the variant with Familial Hemophagocytic Lymphohistiocytosis. Publications report experimental evidence evaluating an impact on protein function, finding that the variant results in diminished degranulation and target cell apoptosis (Benavides_2020, Vinas-Gimenez_2021). However, this does not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 24916509, 33162974, 34630398, 31286990, 37477760). ClinVar contains an entry for this variant (Variation ID: 417965). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Uncertain
0.031
T
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
34
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.82
.;.;D;.
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Pathogenic
1.0
D;D;D;D
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.24
T;T;T;T
MetaSVM
Uncertain
0.16
D
MutationAssessor
Uncertain
2.7
.;.;M;.
PhyloP100
1.9
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-7.3
.;D;D;D
REVEL
Pathogenic
0.66
Sift
Benign
0.070
.;T;T;T
Sift4G
Uncertain
0.0020
D;D;D;D
Polyphen
1.0
.;.;D;D
Vest4
0.72, 0.72
MVP
0.91
MPC
0.44
ClinPred
0.38
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.84
gMVP
0.89
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370053399; hg19: chr19-7706729; API